New Leaf Venture Partners LLC Decreased Oxford Immunotec Global Plc (OXFD) Stake by $6.49 Million

November 10, 2018 - By Ash Bar

Oxford Immunotec Global PLC (NASDAQ:OXFD) Corporate LogoDuring Q2 2018 the big money sentiment increased to 1.5. That’s change of 0.16, from 2018Q1’s 1.34. 5 investors sold all, 21 reduced holdings as OXFD ratio is positive. 26 increased positions while 13 funds took positions. Funds hold 23.43 million shares thus 0.26% more from 2018Q1’s 23.37 million shares. Geode Cap Mgmt Limited Liability Co, Massachusetts-based fund reported 79,350 shs. Consonance Management Limited Partnership has 2.34M shs for 1.94% of their capital. C World Wide Group Holdings A S accumulated 0.03% or 164,073 shs. Moreover, Wells Fargo & Co Mn has 0% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD) for 41,215 shs. Millennium Llc invested in 0% or 16,734 shs. Credit Suisse Ag holds 11,880 shs. Voya Invest Mngmt Limited Liability owns 10,572 shs or 0% of their US capital. Alliancebernstein Limited Partnership has invested 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD). Jane Street Grp Inc Llc invested in 0% or 61,666 shs. Royal Savings Bank Of Canada invested in 130 shs. Legal And General Gp Public has invested 0% of its capital in Oxford Immunotec Global PLC (NASDAQ:OXFD). Citigroup accumulated 3,645 shs or 0% of the stock. Citadel Advisors Ltd Limited Liability Company reported 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD). Wellington Mgmt Gru Llp reported 365,598 shs. 2.24M were reported by Redmile Gp Limited.

OXFD registered $598,000 net activity with 0 insider purchases and 1 sale since September 7, 2018.

In Oxford Immunotec Global Plc (OXFD) was reduced the stake held by New Leaf Venture Partners Llc. The reduction is 63.44% according to 2018Q2 SEC form. The company’s stock popped up 15.22% while New Leaf Venture Partners Llc sold 540,837 shares. At the end of 2018Q2, the hedge fund held 311,660 shares of the in vitro & in vivo diagnostic substances company, valued at $4.02M, down from 852,497 at the end of the previous reported quarter. Oxford Immunotec Global Plc has $410.55M market cap. OXFD hit $15.81 during the last trading session after $0.05 change.Currently Oxford Immunotec Global PLC is uptrending after 1.09% change in last November 10, 2017. OXFD has 113,930 shares volume. The stock underperformed the S&P 500 by 14.53%.

For a total of shares it increased its holding in by shares in the quarter, and has risen its stake in .

Another two news for Oxford Immunotec Global PLC (NASDAQ:OXFD) were briefly announced by: on October 17, 2018 with title “Research Report Identifies Oxford Immunotec Global, Ascena Retail Group, Groupon, Epizyme, Regulus Therapeutics …”. The other‘s article was titled “Oxford Immunotec Reports Third Quarter 2018 Financial Results” and announced on November 09, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.